A Relief for Migraines at last? The Biotech race for the Ultimate Cure

17/03/2016 - 4 minutes

A Migraine is more than just a headache; it is a neurological disorder affecting a staggering 10% of the worldwide population. So where are we on fighting a viable therapy – and who is working on Migraines?

People of all ages are at risk of migraine, with women being three times more likely to suffer from the condition than men. The throbbing head pain is frequently accompanied by nausea, vomiting, and sensitivity to light and sounds.

The attacks can last from a few hours to several days and occur on a daily basis, rendering the sufferers completely debilitated, caused by a wide variety of environmental, chemical and hormonal factors.

Current treatments include pain-killers, vasoconstrictors, Opioids, Glucocorticoids, Beta-blockers, antidepressants, anti-seizure drugs and even Botox injections to the face and neck (to numb the nerves). However, most of these are only effective for relatively mild attacks, have severe side effects – and can even be addictive.

Fortunately, a breakthrough discovery in migraine research may deliver the long overdue relief.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member